FAD/葉酸依存型tRNAメチルトランスフェラーゼ:新しいメチル転送剤としてのフラビン
Djemel Hamdane1, Manuela Argentini, David Cornu
1Laboratoire de Chimie des Processus Biologiques, CNRS-FRE 3488, Collège De France, 11 place Marcelin Berthelot, 75231 Paris Cedex 05, France. djemel.hamdane@college-de-france.fr
Journal of the American Chemical Society
|November 20, 2012
まとめ
TrmFOは独特のtRNAメチルトランスフェラーゼである. 研究者らは,TrmFO内の活性メチル化剤を特定し,メチレン-FADを用いたRNA改変のための新しいメカニズムを明らかにした.
科学分野:
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
- RNA 生物学 RNA 生物学
背景:
- RNAの改変は,構造と機能にとって極めて重要です.
- メチル化は,一般的にS-アデノシルメチオニン (SAM) を使用した最も一般的なRNA改変です.
- TrmFOは,最近発見されたtRNAメチルトランスフェラーゼで,独特のコファクターであるメチレンテトラヒドロフォラートと減少フラビンアデニンジヌクレオチド (FAD) を含んでいます.
研究 の 目的:
- TrmFO媒介のtRNAメチル化の難解なメカニズムを解明するために.
- TrmFO.内の活性メチル化種を特定するために.
- 新種の酵素処理の特徴を述べる.
主な方法:
- 化学添加物を特定するための質量スペクトロメトリ.
- 分子構造を分析するスペクトロスコピ的方法.
- 酵素活性を確認するための生化学分析.
主要な成果:
- TrmFOには,活性なtRNAメチル化剤が含まれています.
- この剤は,オリジナルの酵素-メチレン-FAD共性添加物です.
- 特徴付けには,質量スペクトロメトリー,スペクトロスコピー,および生化学分析が含まれていました.
結論:
- TrmFOによって媒介される新しいtRNAメチル化メカニズムが発見されました.
- 酵素は独特のメチレン-FAD共性添加物を形成する.
- この発見は,RNAの改変経路に関する私たちの理解を広げています.
関連する概念動画
Transfer RNA Synthesis
One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Transfer RNA Synthesis
One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Phase II Reactions: Methylation Reactions
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
tRNA Activation
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Transcription Elongation Factors
Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA into a...
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA into a...


